Serum osteoprotegerin levels are related to height loss: The Tromsø Study
نویسندگان
چکیده
منابع مشابه
Serum osteoprotegerin and renal function in the general population: the Tromsø Study
BACKGROUND Serum osteoprotegerin (OPG) is elevated in patients with chronic kidney disease (CKD) and increases with decreasing renal function. However, there are limited data regarding the association between OPG and renal function in the general population. The aim of the present study was to explore the relation between serum OPG and renal function in subjects recruited from the general popul...
متن کاملBody height and risk of venous thromboembolism: The Tromsø Study.
An association between body height and venous thromboembolism (VTE) has been suggested by previous studies including males only. The aim of this prospective cohort study was to investigate the sex-specific impact of body height on risk of VTE in a general population. Risk factors, including body height and weight, were registered for 26,727 subjects aged 25-96 years who participated in the Trom...
متن کاملSerum lipid levels in relation to serum thyroid-stimulating hormone and the effect of thyroxine treatment on serum lipid levels in subjects with subclinical hypothyroidism: the Tromsø Study.
OBJECTIVE To evaluate the relation between serum thyroid-stimulating hormone (TSH) and lipids. DESIGN Cross-sectional epidemiological study, nested case-control study, and a placebo-controlled double-blind intervention study. METHODS In the 5th Tromsø study serum TSH, total cholesterol (TC), triglycerides (TG), high-density lipoprotein cholesterol (HDL-C), and low-density lipoprotein choles...
متن کاملAssociation of Serum Osteoprotegerin Levels with Bone Loss in Chronic Kidney Disease: Insights from the KNOW-CKD Study
Osteoprotegerin, a potent osteoclast activation inhibitor, decreases bone resorption and positively affects bone mineral density. This study examined the association between serum osteoprotegerin levels and bone loss in patients with chronic kidney disease, a condition associated with increased risk of mineral and bone disorders. The bone mineral densities of the lumbar spine, total hip, and fe...
متن کاملSerum parathyroid hormone (PTH) levels in smokers and non-smokers. The fifth Tromsø study.
OBJECTIVE Smoking is associated with reduced bone density and calcium absorption, and reduced serum levels of vitamin D. A compensatory increase in serum parathyroid hormone (PTH) would therefore be expected as a result of an altered calcium balance. However, reports on PTH levels in smokers are conflicting. As serum PTH levels give important information on the calcium balance, the PTH levels i...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: European Journal of Epidemiology
سال: 2011
ISSN: 0393-2990,1573-7284
DOI: 10.1007/s10654-011-9555-8